Probi AB (publ) (0GZB.L)

203,00 -6,00 (-2,87%) Alla chiusura: 02:15PM BST

Probi AB (publ)

Ideongatan 1A
Lund 223 70
Sweden
46 4 62 86 89 20
https://www.probi.com

Settore/i: 
Settore: 
Impiegati a tempo pieno: 167

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Ms. Anita Johansen	Chief Executive Officer	3,99M	N/D	1972
Mr. Per Lindblad	Chief Financial Officer	N/D	N/D	1966
Mr. Jim Anthony	Interim Vice President of Operations	N/D	N/D	1970
Ms. Martina Pettersson	Global Marketing Director	N/D	N/D	1973
Ms. Basudha Bhattarai-Johansson	Vice President of Human Relations & Sustainability	N/D	N/D	1983
Ms. Veronica Dong	Head of APAC - Singapore	N/D	N/D	N/D
Ms. Karen Ong	Head of Asia-Pacific	N/D	N/D	1972
Ms. Magdolna Dimén	Group Controller	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in SEK.

Descrizione

Probi AB (publ) researches, manufactures, and sells probiotics for dietary supplements and food companies in North America, South America, Europe, Sweden, the Middle East, Africa, Asia Pacific, and internationally. The company conducts research primarily in the fields of mental, digestive, immune, bone, oral, children's, women's, and senior health, as well as iron absorption. It provides dietary supplement, and food and beverage products in the form of capsules, tablets and spheres, chewable tablets, powder, fruit drinks, shots, carbonated beverages, chilled diary and plant based products, frozen desserts and ice-cream, powder formulas, and recovery drinks. In addition, the company offers Probi Sensia, a proprietary probiotic strain clinically shown to enhance cognition by boosting learning and working memory; Probi Digestis for support gastrointestinal health; Probi Defendum which provides positive impact on immune health; Probi FerroSorb, a probiotic iron-absorption concept, to support long-term iron status; Probi Osteo for bone health; BLIS by Probi offers unique way to boost oral health with probiotics; Probi LiveBac provides live and active probiotic cultures for dietary supplements and functional food product; and LP299V for human gastrointestinal tract and adhere to intestinal epithelial cells to boost health benefits. It has a collaboration with Örebro University for research into exploration needle free vaccines; University of Gothenburg to investigate the effects of probiotic strain LP299V on iron absorption; Wageningen University & Research to understand the molecular interactions occurring between microbes and its hosts; University of Umeå to investigate the effects of the strain LP299V on iron status in female athletes; and University of Aberdeen to characterize bacterial isolates with next generation probiotics. Probi AB (publ) was incorporated in 1991 and is headquartered in Lund, Sweden. Probi AB (publ) is a subsidiary of Symrise AG.

Governance aziendale

L'ISS Governance QualityScore di Probi AB (publ) al 29 aprile 2024 è 3. I criteri di valutazione fondamentali sono revisione: 6; Consiglio di Amministrazione: 5; diritti degli azionisti: 6; retribuzione: 3.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.